SCHEMBL22911955

SCHEMBL22911955

C[Si](C)(C)C#Cc1cnc(Cl)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29596517 0.76 HDAC1 (0.31) —
SCHEMBL22911964 0.76 HDAC1 (0.31) —
SCHEMBL14299556 0.72 GRM5 (0.31) —
SCHEMBL22911956 0.71 — —
SCHEMBL15570420 0.68 — —
SCHEMBL8973225 0.68 ADRA2A (0.36) —
SCHEMBL1163938 0.67 CSNK1A1 (0.39) —
SCHEMBL708713 0.67 FFAR1 (0.42) —
SCHEMBL20929102 0.65 GRM5 (0.30) —
SCHEMBL18913628 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388990-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES KINNATE BIOPHARMA INC. 2022-12-08 — — US disclosed
EP-3999498-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES Kinnate Biopharma Inc. (US) 2022-05-25 — — EP disclosed
CN-114401955-A Inhibitors of cyclin dependent kinases 金耐特生物制药公司 2022-04-26 — — CN disclosed
WO-2021011796-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES KINNATE BIOPHARMA INC. (US) 2021-01-21 — — WO disclosed
Send feedback